| Generic Name | Originator | World Status | Any Pharmacology Description | Any Indication | Any Indication Status | Notes |
|---|---|---|---|---|---|---|
| ghrelin, Daiichi | Daiichi Sankyo | Phase I Clinical Trial | Growth hormone secretagogue receptor agonist | Cachexia Anorexia nervosa |
Phase I Clinical Trial Phase I Clinical Trial |
|
| CRF-2 antagonist, Neurocrine | Neurocrine Biosciences | Preclinical | Corticotropin releasing factor 2 receptor antagonist | Obesity Anorexia nervosa |
Preclinical Preclinical |
|
| Table 2 - Drugs in active development for the treatment of anorexia nervosa. | ||||||